Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanse Patients With COPD
This study has been completed.
Study NCT00824382   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received on January 15, 2009.   Last Updated on October 18, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Disease Attributes
Lung Diseases, Obstructive
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
BI 1744 CL 2 µg
BI 1744 CL 5 µg
BI 1744 CL 10 µg
Placebo
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services